Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus.

The Korean journal of hepatology

Volumn 17, Issue 3, 2011, Pages 199-205

  Kim, Yu Jin ^a   Lee, Jin Woo ^b   Kim, Yun Soo ^b   Jeong, Sook Hyang ^b   Kim, Young Seok ^b   Yim, Hyung Joon ^b   Kim, Bo Hyun ^b   Lee, Chun Kyon ^b   Park, Choong Kee ^b   Park, Sang Hoon ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; RIBAVIRIN; VIRUS DNA;

ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DRUG COMBINATION; FEMALE; GENETICS; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; PATHOLOGY;

ADULT; ANTIVIRAL AGENTS; CROSS-SECTIONAL STUDIES; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN;

EID: 84872097828     PISSN: None     EISSN: 20938047     Source Type: Journal    
DOI: 10.3350/kjhep.2011.17.3.199     Document Type: Article

References (0)